Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Scientific Reports|March 1, 2019
Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMsBetul Gok Yavuz, Gurcan Gunaydin, M Emre Gedik, et al.
Trends in Cancer|December 3, 2025
Mapping heterogeneity in the tumor microenvironment of renal cell carcinoma through single-cell omicsBetul Gok Yavuz, Narmina Khanmammadova, Zuhair Majeed, et al.
Journal of Hepatocellular Carcinoma|October 1, 2021
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular CarcinomaBetul Gok Yavuz, Elshad Hasanov, Sunyoung S Lee, et al.
NPJ Precision Oncology|March 6, 2025
Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinomaVinita Akula, Lily Chen, Yusuf Acikgoz, et al.
Journal of Gastrointestinal Cancer|September 27, 2025
Comprehensive Review of Transarterial Chemoembolization Plus Systemic Therapy in Advanced Hepatocellular CarcinomaArif Akyildiz, Betul Gok Yavuz, Rashad Ismayilov, et al.
Oncotarget|April 15, 2020
Origin and role of hepatic myofibroblasts in hepatocellular carcinomaBetul Gok Yavuz, Roberto Carmagnani Pestana, Yehia I Abugabal, et al.
Frontiers in Pharmacology|February 21, 2024
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infectionAbdelrahim Maen, Betul Gok Yavuz, Yehia I Mohamed, et al.
Cancers|October 14, 2023
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular CarcinomaBetul Gok Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular CarcinomaShadi Chamseddine, Betul Gok Yavuz, Yehia I Mohamed, et al.
Pageof 2